These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16682002)
41. A proteomic snapshot of the human heat shock protein 90 interactome. Falsone SF; Gesslbauer B; Tirk F; Piccinini AM; Kungl AJ FEBS Lett; 2005 Nov; 579(28):6350-4. PubMed ID: 16263121 [TBL] [Abstract][Full Text] [Related]
43. Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo. Papathanassiu AE; MacDonald NJ; Emlet DR; Vu HA Cell Stress Chaperones; 2011 Mar; 16(2):181-93. PubMed ID: 20927616 [TBL] [Abstract][Full Text] [Related]
44. The inhibitor protein of the F1F0-ATP synthase is associated to the external surface of endothelial cells. Cortés-Hernández P; Domínguez-Ramírez L; Estrada-Bernal A; Montes-Sánchez DG; Zentella-Dehesa A; de Gómez-Puyou MT; Gómez-Puyou A; García JJ Biochem Biophys Res Commun; 2005 May; 330(3):844-9. PubMed ID: 15809073 [TBL] [Abstract][Full Text] [Related]
45. Characterization of Myelin Sheath F(o)F(1)-ATP synthase and its regulation by IF(1). Ravera S; Panfoli I; Aluigi MG; Calzia D; Morelli A Cell Biochem Biophys; 2011 Mar; 59(2):63-70. PubMed ID: 20809181 [TBL] [Abstract][Full Text] [Related]
46. ATP Acyl Phosphate Reactivity Reveals Native Conformations of Hsp90 Paralogs and Inhibitor Target Engagement. Nordin BE; Liu Y; Aban A; Brown HE; Wu J; Hainley AK; Rosenblum JS; Nomanbhoy TK; Kozarich JW Biochemistry; 2015 May; 54(19):3024-36. PubMed ID: 25905789 [TBL] [Abstract][Full Text] [Related]
47. Assembly factors of F1FO-ATP synthase across genomes. Pícková A; Potocký M; Houstek J Proteins; 2005 May; 59(3):393-402. PubMed ID: 15789402 [TBL] [Abstract][Full Text] [Related]
48. Modulation of the protein kinase Cdelta interaction with the "d" subunit of F1F0-ATP synthase in neonatal cardiac myocytes: development of cell-permeable, mitochondrially targeted inhibitor and facilitator peptides. Nguyen TT; Ogbi M; Yu Q; Fishman JB; Thomas W; Harvey BJ; Fulton D; Johnson JA J Biol Chem; 2010 Jul; 285(29):22164-73. PubMed ID: 20460381 [TBL] [Abstract][Full Text] [Related]
49. Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors. Atwal KS; Wang P; Rogers WL; Sleph P; Monshizadegan H; Ferrara FN; Traeger S; Green DW; Grover GJ J Med Chem; 2004 Feb; 47(5):1081-4. PubMed ID: 14971888 [TBL] [Abstract][Full Text] [Related]
50. Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions. Momose I; Ohba S; Tatsuda D; Kawada M; Masuda T; Tsujiuchi G; Yamori T; Esumi H; Ikeda D Biochem Biophys Res Commun; 2010 Feb; 392(3):460-6. PubMed ID: 20083087 [TBL] [Abstract][Full Text] [Related]
52. The role of HSP90 molecular chaperones in hepatocellular carcinoma. Nouri-Vaskeh M; Alizadeh L; Hajiasgharzadeh K; Mokhtarzadeh A; Halimi M; Baradaran B J Cell Physiol; 2020 Dec; 235(12):9110-9120. PubMed ID: 32452023 [TBL] [Abstract][Full Text] [Related]
53. The chaperone system in cancer therapies: Hsp90. Basset CA; Conway de Macario E; Leone LG; Macario AJL; Leone A J Mol Histol; 2023 Apr; 54(2):105-118. PubMed ID: 36933095 [TBL] [Abstract][Full Text] [Related]
54. Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity. Byun JK; Lee SH; Moon EJ; Park MH; Jang H; Weitzel DH; Kim HH; Basnet N; Kwon DY; Lee CT; Stephenson TN; Jeong JH; Patel BA; Park SJ; Chi JT; Dewhirst MW; Hong J; Lee YM Br J Cancer; 2023 Apr; 128(8):1491-1502. PubMed ID: 36759727 [TBL] [Abstract][Full Text] [Related]
55. Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity. Seclì L; Avalle L; Poggio P; Fragale G; Cannata C; Conti L; Iannucci A; Carrà G; Rubinetto C; Miniscalco B; Hirsch E; Poli V; Morotti A; De Andrea M; Turco E; Cavallo F; Fusella F; Brancaccio M Cancer Res; 2021 Sep; 81(18):4794-4807. PubMed ID: 34193441 [TBL] [Abstract][Full Text] [Related]
56. Natural products and other inhibitors of F Patel BA; D'Amico TL; Blagg BSJ Eur J Med Chem; 2020 Dec; 207():112779. PubMed ID: 32942072 [TBL] [Abstract][Full Text] [Related]
57. Inhibitors of F Denny WA Future Med Chem; 2021 May; 13(10):911-926. PubMed ID: 33845594 [TBL] [Abstract][Full Text] [Related]
58. A Therapeutic Connection between Dietary Phytochemicals and ATP Synthase. Ahmad Z; Hassan SS; Azim S Curr Med Chem; 2017 Nov; 24(35):3894-3906. PubMed ID: 28831918 [TBL] [Abstract][Full Text] [Related]
59. An HSP90 cochaperone Ids2 maintains the stability of mitochondrial DNA and ATP synthase. Jiang PH; Hou CY; Teng SC BMC Biol; 2021 Nov; 19(1):242. PubMed ID: 34763695 [TBL] [Abstract][Full Text] [Related]
60. Heat shock protein 90 in neurodegenerative diseases. Luo W; Sun W; Taldone T; Rodina A; Chiosis G Mol Neurodegener; 2010 Jun; 5():24. PubMed ID: 20525284 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]